Sign In
Buy PBYI
$6.81
-0.170 (-2.44%)
At Close: Jun 03, 2026
Snap These 4 Top-Performing Liquid Stocks for Strong Returns
07:31am, Monday, 11'th Dec 2023
Here are four top-ranked liquid stocks, Puma Biotechnology (PBYI), Amphastar Pharmaceuticals (AMPH), DropBox (DBX) and GigaCloud Technology Inc. (GCT), which investors can add to their portfolio for s
Here Is Why Bargain Hunters Would Love Fast-paced Mover Puma Biotech (PBYI)
10:32am, Friday, 01'st Dec 2023
Puma Biotech (PBYI) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks th
4 Top-Performing Liquid Stock Picks for Robust Returns
09:46am, Thursday, 30'th Nov 2023
Here are four top-ranked liquid stocks, Puma Biotechnology (PBYI), Amphastar Pharmaceuticals (AMPH), DropBox (DBX), and Vimeo (VMEO), which investors can add to their portfolio for solid gains.
Here's Why You May Invest in Puma Biotechnology (PBYI) Stock
01:32pm, Monday, 20'th Nov 2023
Here, we discuss some reasons why investing in Puma Biotechnology (PBYI) stock now may turn out to be a more prudent move than ever.
PBYI vs. TECH: Which Stock Is the Better Value Option?
12:47pm, Monday, 20'th Nov 2023
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Puma Biotech (PBYI) or Techne (TECH). But which of these two stocks is more attractive to val
Puma Biotech (PBYI) Q3 Earnings Beat, Revenues Lag Estimates
01:32pm, Friday, 03'rd Nov 2023
Puma Biotech's (PBYI) third-quarter 2023 earnings beat estimates, while revenues miss the same. The company tightens the full-year revenue guidance.
Puma Biotechnology, Inc. (PBYI) Q3 2023 Earnings Call Transcript
10:21pm, Thursday, 02'nd Nov 2023
Puma Biotechnology, Inc. (NASDAQ:PBYI ) Q3 2023 Earnings Conference Call November 2, 2023 4:30 PM ET Company Participants Mariann Ohanesian - Senior Director, IR Alan Auerbach - Chairman, President an
Puma Biotech (PBYI) Tops Q3 Earnings Estimates
07:32pm, Thursday, 02'nd Nov 2023
Puma Biotech (PBYI) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Estimate of $0.15 per share. This compares to loss of $0.01 per share a year ago.
PBYI or TECH: Which Is the Better Value Stock Right Now?
12:47pm, Thursday, 02'nd Nov 2023
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Puma Biotech (PBYI) and Techne (TECH). But which of these two stocks offers value investors a better bang for
Puma Biotech (PBYI) Loses -18.62% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
11:19am, Friday, 20'th Oct 2023
The heavy selling pressure might have exhausted for Puma Biotech (PBYI) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analys
Puma Biotechnology to Host Conference Call to Discuss Third Quarter 2023 Financial Results
04:14pm, Thursday, 19'th Oct 2023
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology will host a conference call at 1:30 p.m. PDT/4:30 p.m. EDT on Thursday, Nov. 2, 2023, following the release of its 3Q-2023 results.
PBYI vs. AMGN: Which Stock Is the Better Value Option?
12:46pm, Tuesday, 17'th Oct 2023
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Puma Biotech (PBYI) or Amgen (AMGN). But which of these two stocks is more attractive to valu
Puma's (PBYI) Alisertib Gets FDA's Orphan Drug Tag for SCLC
09:01am, Friday, 22'nd Sep 2023
Puma's (PBYI) alisertib receives the Orphan Drug designation from the FDA for treating patients with small cell lung cancer.
Puma Biotechnology to Present at the H.C. Wainwright 25th Annual Global Investment Conference
04:07pm, Thursday, 31'st Aug 2023
LOS ANGELES--(BUSINESS WIRE)--Alan Auerbach, CEO of Puma Biotechnology, will present a corporate update at the H.C. Wainwright Global Investment Conference beginning on 9/11/23.
Puma Biotech (PBYI) Q2 Earnings Beat, Nerlynx Sales Outperform
02:17pm, Friday, 04'th Aug 2023
Puma Biotechnology (PBYI) beats second-quarter earnings and sales estimates. Stock rises in after-hours.
